Skip to search formSkip to main contentSkip to account menu

N-acetylglucopyranosylamine

Known as: 1-GlcNAc, N-acetyl-beta-D-glucopyranosylamine 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Glucosamine
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
N-Acetyl-β-D-glucopyranosylamine 6-phosphate is a specific inhibitor of glycogen-bound protein phosphatase 1
Previous work has shown that the C-1-substituted glucoseanalogue N-acetyl-β--glucopyranosylamine (1-GlcNAc) is a competitive… 
Highly Cited
1995
Highly Cited
1995
N‐acetyl‐β‐D‐glucopyranosylamine: A potent T‐state inhibitor of glycogen phosphorylase. A comparison with α‐D‐glucose
Structure‐based drug design has led to the discovery of a number of glucose analogue inhibitors of glycogen phosphorylase that… 
1995
1995
Effects of C-1-substituted glucose analogue on the activation states of glycogen synthase and glycogen phosphorylase in rat hepatocytes.
A series of glucose-analogue inhibitors of glycogen phosphorylase b (GPb) has been designed, synthesized and investigated in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)